Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats


This study was designed to investigate the effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in alloxan-induced diabetic rats. Thirty-two albino male rats, weighing 234±34 g, were divided into four experimental groups (control, diabetic, diabetic+zinc supplemented and diabetic+ magnesium supplemented). The experiment lasted for 60 d. The first 45 d of the experiment was the supplementation and last 15 d was the supplementation and diabetes-inducing period. Diabetic+zinc-supplemented and diabetic+magnesium-supplemented groups were given orally (by adding in their drinking water) 227 mg/L of zinc and 100 mg/kg body weight (bw) of magnesium, respectively throughout the experiment. Control and diabetic groups served as controls and did not receive zinc or magnesium supplementation. Diabetic, diabetic+zinc-supplemented, and diabetic+magnesium-supplemented groups were given a daily injection (ip) of 100 mg/kg bw of alloxan for 15 d starting on d 46 of the experiment. The control group was only injected with the same volume of isotonic NaCl as the diabetic group received. At the end of the of the experiment, rats in all four groups were fasted for 12 h and blood samples were taken from the heart under ether anesthesia for the determination of thyroid hormone, glucose, total cholesterol, and triglyceride concentrations. It was found that serum glucose, total cholesterol, and triglyceride concentrations were higher and serum T3 and T4 concentrations were lower in diabetic rats than those in the control group. Zinc supplementation did not change any parameter in diabetic rats. However, magnesium supplementation decreased the elevated total cholesterol and triglyceride concentrations of the diabetic rats to the control level. It was concluded that oral magnesium supplementation might decrease the diabetes-induced disturbances of lipid metabolism.

This is a preview of subscription content, access via your institution.


  1. 1.

    D. K. Granner, Hormones of the pancreas and gastrointestinal tract, in Harper’s Biochemistry, R. K. Murray, D. K. Granner, P. A. Mayes, and V. W. Rodwell, eds., Lange Medical Publications, CT, pp. 568–569 (1993).

    Google Scholar 

  2. 2.

    D. B. Sacks, Implications of the revised criteria for diagnosis and classification of diabetes mellitus, Clin. Chem. 43, 2230–2233 (1997).

    PubMed  CAS  Google Scholar 

  3. 3.

    F. Turkmen, I. Akkus, S. Buyukbas, and A. Cigli, Complications and biochemical changes in diabetes mellitus, T. Klin. Tip. Bil. 10, 1–10 (1990).

    Google Scholar 

  4. 4.

    J. H. Oppenheimer, H. L. Schwartz, C. N. Mariash, W. B. Kinlaw, N. C. W. Wong, and H. C. Freake, Advances in our understanding of thyroid hormone action at the cellular levels, Endocr. Rev. 8, 288–308 (1987).

    PubMed  CAS  Article  Google Scholar 

  5. 5.

    N. Bagchi, N. Palaniswami, H. Desai, J. Felicetta, and T. R. Brown, Decreased thyroidal response to thyrotropin in type II diabetes mellitus, Metabolism 37, 669–671 (1988).

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    L. A. Gavin, F. A. McMahon, and M. Moelier, The mechanism of impaired T3 production from T4 in diabetes, Diabetes 30, 694–699 (1981).

    PubMed  CAS  Google Scholar 

  7. 7.

    E. Sluszkiewicz, Thyroid function in insulin-dependent diabetic children, Exp. Clin. Endocrinol. 87, 345–348 (1986).

    PubMed  CAS  Article  Google Scholar 

  8. 8.

    S. Fujimato, Y. Indo, A. Higashi, I. Matsuda, N. Kashiwabara, and I. Nakashima, Conversion of thyroxine into tri-iodothyronine in zinc-deficient rat liver, J. Pediatr. Gastroenterol. Nutr. 5, 799–805 (1986).

    Article  Google Scholar 

  9. 9.

    M. Yenigun, Cardiovascular Diabetes, Istanbul University Press, Istanbul (1997).

    Google Scholar 

  10. 10.

    F. Corica, A. Allegra, A. Di Benedetto, M. S. Giacobbe, G. Romano, D. Cucinotta, et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus, Magnesium Res. 7, 43–47 (1994).

    CAS  Google Scholar 

  11. 11.

    T. W. Balon, J. J. Gu, Y. Tokuyama, A. P. Jasman, and J. J. Nadler, Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM, Am. J. Physiol. 269, E745-E752 (1995).

    PubMed  CAS  Google Scholar 

  12. 12.

    M. Kimura, M. Ujihara, and K. Yokoi, Tissue manganese levels and liver pyruvate carboxylase activity in magnesium-deficient rats, Biol. Trace. Element Res. 52, 171–179 (1996).

    Google Scholar 

  13. 13.

    A. Goel, D. Dhawan, and S. Kheruka, Evaluation of zinc in the regulation of serum T3 and T4 levels and hepatic functions in carbontetrachloride-intoxicated rats, Biol. Trace. Element Res. 41, 59–68 (1994).

    CAS  Article  Google Scholar 

  14. 14.

    Y. Yamaguchi, S. Kitagawa, M. Kunitomo, and M. Fujiwara, Preventive effects of magnesium on raised serum lipid peroxide levels and aortic cholesterol deposition in mice fed an atherogenic diet, Magnesium Res. 7, 31–37 (1994).

    CAS  Google Scholar 

  15. 15.

    M. Yenson, Clinical Biochemistry, 6th ed., Beta, Istanbul (1986).

    Google Scholar 

  16. 16.

    A. L. Bobson, IMMULITE Automated Immunoassay System, J. Clin. Immunassay 14, 83–88 (1991).

    Google Scholar 

  17. 17.

    C. Douillet, Y. Chancerelle, C. Cruz, C. Morancles, J. F. Kergonou, S. Renaud, et al. High dosage vitamin E effect on oxidative status and serum lipids distribution in streptozotocin-induced diabetic rats, Biochem Med. Metab. Biol. 50, 265–276 (1993).

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    S. Ekin and N. Mert, Investigation of trace elements (Cu, Zn, Fe, Cr, Mn), minerals (Mg, K), total sialic acid and lipid-bound sialic acid levels in patients with non-insulin dependent diabetes mellitus, Ph. D. thesis, Yuzuncu Yil University, Health Sciences Institute (2001).

  19. 19.

    G. M. Reaven and M. S. Greenfield, Diabetic hypertriglyceridemia. Evidence for three clinical syndromes, Diabetes 30, 66–75 (1981).

    PubMed  CAS  Google Scholar 

  20. 20.

    G. M. Reaven and C. E. Mondon, Effect of in vivo plasma insulin levels on the relationship between perfuse free fatty acid concentration and triglyceride secretion by perfused rat livers, Horm. Metab. Rev. 16, 230–232 (1984).

    CAS  Google Scholar 

  21. 21.

    G. M. Reaven, Role of insulin resistance in human disease, Diabetes 37, 1595–1607 (1988).

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    E. Gueux. A. Mazur, P. Cardot, and Y. Rayssiguier, Magnesium deficiency affects plasma lipoprotein composition in rats, J. Nutr. 121, 1222–1227 (1991).

    PubMed  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Burhanettin Baydas.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baydas, B., Karagoz, S. & Meral, I. Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats. Biol Trace Elem Res 88, 247–253 (2002). https://doi.org/10.1385/BTER:88:3:247

Download citation

Index Entries

  • Diabetes
  • rat
  • zinc
  • magnesium
  • thyroid hormone
  • lipid